ArticleAmerican journal of cancer research2022

Peruvoside is a novel Src inhibitor that suppresses NSCLC cell growth and motility by downregulating multiple Src-EGFR-related pathways.

Yihua Lai et al.PubMed ↗Full text ↗

No numbers read from the abstract.